# Pemetrexed, Cisplatin With Soft Tissue Sarcoma

> **NCT04605770** · PHASE2 · RECRUITING · sponsor: **Yonsei University** · enrollment: 164 (estimated)

## Conditions studied

- Sarcoma,Soft Tissue

## Interventions

- **DRUG:** pemetrexed+cisplatin

## Key facts

- **NCT ID:** NCT04605770
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-22
- **Primary completion:** 2027-11-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04605770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04605770, "Pemetrexed, Cisplatin With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04605770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*